Navigation Links
Breast cancer patients prefer silicone over saline implants after mastectomy
Date:11/8/2010

A new study has found that women who receive silicone implants after a double mastectomy are more satisfied with their breasts than women who receive saline implants. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help physicians and breast cancer survivors as they together make decisions related to postmastectomy reconstructive surgery.

Women who have one or both of their breasts removed as a treatment for breast cancer may wish to undergo breast reconstructive surgery with implants. Such postmastectomy implants may be filled with either saline (salt water) or silicone gel, and while both types have been approved by the US Food and Drug Administration, the safety and effectiveness of breast implants remain under close scrutiny. In addition to safety and efficacy, patient satisfaction and quality of life are also important considerations when comparing implant types. To this end, Colleen McCarthy, MD, of Memorial Sloan-Kettering Cancer Center in New York City led a team that surveyed 672 women who had undergone postmastectomy reconstructive surgery with implants at one of three centers in North America.

A total of 472 patients in the study completed questionnaires. In 176 women, silicone implants were placed; in 306, saline implants were used. The investigators found that patients with silicone implants were more satisfied with their reconstructed breasts than patients with saline implants. Receiving radiation therapy after a mastectomy had a significantly negative effect on breast satisfaction in both silicone and saline implant recipients. In addition, for women who received either silicone or saline implants, satisfaction diminished over time.

"We now know that women who elect to proceed with the placement of a silicone implant report higher satisfaction with their reconstructed breasts than those who choose saline implants," said Dr. McCarthy. "It also appears that patient satisfaction with postmastectomy implant-based reconstruction is generally high and that individual treatment variablessuch as implant typeexplain only a relatively small amount of the variance. Patient counseling should reflect these realities in order to reassure patients that high satisfaction may be obtained with both saline and silicone implants," she added.


'/>"/>

Contact: Jennifer Beal
healthnews@wiley.com
44-012-437-70633
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. Even the sickest babies benefit from breast-feeding
2. Consuming vegetables linked to decreased breast cancer risk in African-American women
3. Clue to unusual drug-resistant breast cancers found
4. Breast density linked to increased risk of subsequent breast cancer
5. Black mothers cite lack of desire as top reasons for not breastfeeding
6. Breast cancer diagnostic delay depends more on race than insurance
7. Decreased survival for Puerto Rican women with triple-negative breast cancer subtype
8. Racial differences in breast cancer treatment persist despite similar economics
9. Marshall University researchers awarded more than $1 million for breast cancer studies
10. Fat stem cells safe for breast reconstruction when cancer is dormant, says Pitt team
11. Alcohol consumption after breast cancer diagnosis may increase recurrence risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... -- Demonstrating its ongoing commitment to patient safety, Blue ... has now fully integrated THE OBSERVER technology ... OBSERVER is a system for actively monitoring the cleaning, ... compliance with safety best practices and is Prairie Dog ... growth and spread of infections within the health care ...
(Date:1/24/2017)... , Jan. 24, 2017  Neogen Corporation (NASDAQ: ... terminated its agreement with SenesTech Incorporated (NASDAQ: ... a rodenticide being developed by SenesTech. The two firms ... time when the SenesTech product was approved by the ... approval provided that the product could only be used ...
(Date:1/24/2017)... , Jan. 24, 2017   Bracket , ... today announced the addition of Jennifer Peters ... Vice President and General Manager for the Scientific Services ... for Bracket,s work in Rater Training, Quality Assurance, and ... with a strong skillset and demonstrated record building technology-based ...
(Date:1/24/2017)... GA (PRWEB) , ... January 24, 2017 , ... ... and instrument solutions, announces the appointment of Steven F. McAllister as Executive Vice ... device experience in both the U.S. and international markets. Beginning his career at ...
Breaking Biology Technology: